Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice-Reference-Cited by-同舟云学术

Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice

Published:2014-05 Issue:25 Volume:32 Page:3066-3074
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Takei Saki,Omoto Chika,Kitagawa Koichi,Morishita Naoya,Katayama Takane,Shigemura Katsumi,Fujisawa Masato,Kawabata Masato,Hotta Hak,Shirakawa Toshiro

Funder

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Japan Science and Technology Agency

Japan International Cooperation Agency

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference39 articles.

1. Hepatitis C: global prevalence;World Health Organization;Wkly Epidemiol Rec,1997

2. Sequence analysis of the core gene of 14 hepatitis C virus genotypes;Bukh;Proc Natl Acad Sci U S A,1994

3. Hepatitis C;Brody;Nature,2011

4. Innate immune responses in hepatitis C virus infection;Li;Semin Immunopathol,2013

5. Optimal therapy of hepatitis C;Di Bisceglie;Hepatology,2002

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy;Journal of Nanobiotechnology;2024-08-24

2. An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model;Scientific Reports;2023-06-20

3. An oral cancer vaccine using a Bifidobacterium vector enhances the efficacy of combination therapy with anti-PD-1 and anti-CTLA-4 antibodies in a mouse renal cell carcinoma model;2023-01-04

4. Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health;Gut Microbes;2022-08-12

5. An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model;Molecular Therapy - Oncolytics;2021-09